Dulaglutide DULA

An FDA-approved once-weekly injectable diabetes medication (Trulicity). Large studies confirm it lowers blood sugar and reduces heart-related risks, with nausea and reduced appetite as the most common side effects.

Also known as Trulicity

Effects Lose fat

Routes Subcutaneous

Legal status Prescription drug

WADA Not listed

Reported dosing

Approved label

What has been reported in the literature and by users. This is a record of what is done, not a recommendation.

Typical dose 0.75-1.5 mg once weekly

Reported range 0.75-4.5 mg once weekly

Route Subcutaneous injection

Frequency Once weekly

Duration Chronic/ongoing (as prescribed)

FDA-approved GLP-1 receptor agonist (Trulicity) for type 2 diabetes.

Where this comes from FDA prescribing information

These figures are recorded for reference and are not a recommendation. Dosing is a decision for you and a clinician.